A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lungLo M. Sosinski, Robert A. Quinn, Marc McClelland et al.|Journal of Cystic Fibrosis|2021Cited by 71
Complex and unexpected outcomes of antibiotic therapy against a polymicrobial infectionLydia-Ann J. Ghuneim, Robert A. Quinn, Isaac Klapper et al.|The ISME Journal|2022Cited by 35
525: Elexacaftor/tezacaftor/ivacaftor therapy alters the CF lung mucus metabolome, reshaping microbiome niche spaceRobert A. Quinn, Douglas Conrad, Marc McClelland et al.|Journal of Cystic Fibrosis|2021Cited by 1
Trikafta therapy alters the CF lung mucus metabolome reshaping microbiome niche spaceLauren M. Sosinski, Robert A. Quinn, Jenna Mielke et al.|medRxiv|2021Cited by 0